We report an extremely rare case of abnormal vaginal bleeding in a 66-year postmenopausal woman. A sterile speculum examination revealed no obvious tumour mass in the cervix. Serum levels of cancer antigen 125 and carcinoembryonic antigen were elevated at 480.3 IU/L and 19.3 ng/ml, respectively. Ultrasound showed a 4 × 3 × 2 cm hypoechoic solid mass on the left uterine adnexa, a 4-5 cm mass in the right adnexa, a 4 cm mass in the vesicouterine excavation and a 4-5 cm mass in the omentum. Finally, debulking surgery with tumour resection was performed. The bilateral ovarian tumours showed an infiltrative pattern of stromal invasion. Lymphovascular tumour emboli were present in bilateral ovaries. A careful histological examination revealed an eosinophilic cytoplasm that focally formed pear-like structures in the local area of the left ovary. Immunochemical analysis aided in the diagnosis of cervical squamous cell carcinoma involving the ovaries, fallopian tubes, uterine serosa, vesicouterine excavation, mesoappendix, mesentery, omentum, and paracolic sulcus. She was treated with surgery followed by cisplatin-based combination chemotherapy.
INTRODUCTION
Cervical carcinoma is one of the most common malignant tumours in women. The clinical presentation may include vaginal bleeding, vaginal drainage, increased urinary frequency, urgency, constipation or a pelvic mass. Cervical carcinoma generally spreads upward to the parametrial tissue and infiltrates the uterine wall through the lymphatic vessels. Ovarian metastasis from cervical carcinoma is very rare except in the late stage of cancer, when it occurs frequently. 1 We present a rare case of cervical squamous cell carcinoma (SCC) involving the ovaries, fallopian tubes, uterine serosa, vesicouterine excavation, mesoappendix, mesentery, omentum, and paracolic sulcus mimicking a primary high-grade serous ovarian carcinoma.
CASE REPORT
A 66-year woman with a history of high-grade squamous intraepithelial lesions presented to our hospital for a loop electrosurgical excision procedure with positive margins. A cervical examination revealed no obvious mass in the cervix. Serum levels of cancer antigen 125 and carcinoembryonic antigen were elevated at 480.3 IU/L and 19.3 ng/ml, respectively. Transvaginal ultrasonography identified a 4 × 3 × 2 cm hypoechoic solid mass on the left uterine adnexa, a 4-5 cm mass in the right adnexa, a 4 cm mass in the vesicouterine excavation and a 4-5 cm mass in the omentum. Pelvic and periaortic lymph nodes were normal. Consequently, surgical treatment was planned.
A 5 × 5 × 4 cm mass was seen in the left ovary at laparotomy, and a 4-5 cm mass seen in the right ovary was tightly adhered to the uterine serosa and pelvic peritoneum. Some other tumours (0.2-4 cm) in the vesicouterine excavation, mesoappendix, mesentery, omentum, paracolic sulcus and bilateral tubal serosa were also detected. Malignant cells were identified by subsequent peritoneal washings. Thus, tumours of the peritoneum, mesoappendix and mesentery were carefully removed. Finally, debulking surgery with tumour resection, including a total hysterectomy, bilateral salpingo-oophorectomy, appendectomy and omentum resection were completed. Bilateral pelvic lymph nodes were also removed. The left ovarian mass was strongly positive for p16 and negative for PAX8, p53, Wilms tumour 1 (WT1), oestrogen receptor (ER) and progesterone receptor (PR), with a high Ki67 index. Pear-like structures seen in the left ovary were positive for p63 (Figure 2 ).
Taking into account the above features, the diagnosis was made as cervical SCC involving the ovaries, fallopian tubes, uterine serosa, vesicouterine excavation, mesoappendix, mesentery, omentum and paracolic sulcus. Subsequently, she was treated with cisplatinbased combination chemotherapy.
DISCUSSION
Primary ovarian and metastatic tumours of the ovaries can be distinguished by their characteristic microscopic and general morphology. In this case, bilaterality, a normal-sized ovary, ovarian surface involvement and the presence of a tumour thrombus characterised the ovarian metastatic tumour. Additionally, primary SCC can occur as a teratoma, endometriosis or Brenner's tumour, 2 but no evidence of these was found. Cervical SCC was confirmed and was considered to be the origin of the ovarian metastatic tumour.
However, the ovarian tumour described here bore some resemblance to serous carcinomas, as illustrated by its solid low differentiated morphology, rounded nuclei, and distinct nucleoli with many mitotic figures. Ovarian serous carcinoma is much more common than primary ovarian SCC. 3 Thus, immunohistochemical markers, including p16, p63, PAX8, WT1, p53, ER and PR were used to distinguish the primary ovarian serous carcinomas from ovarian metastatic SCC.
Both Herpes virus (HPV)-related and non-HPV-related cancers can be strongly positive for p16. Notably, p16 over-expression is more frequently seen in serous carcinomas. 4 PAX8 is a conserved transcription factor with essential roles in Mullerian duct development. Its expression is necessary for maintenance of epithelial cells of the uterus, fallopian tubes and ovaries. 5 p53, which is a tumour suppressor gene, is typically overexpressed in serous carcinomas and is considered a very useful marker for serous carcinomas of the ovary (OSC). 6 WT1 has an essential role in the normal development of the kidneys and gonads and has frequently been used as a surrogate marker for OSC. Although the ER is widely found in the upper genital tract, it is frequently expressed in OSC, but not in most cervical carcinomas. 7 p63 is a homologue of the tumour suppressor gene p53 that is preferentially expressed in human basal squamous epithelium and can be distinguished by its morphological features of squamous or glandular differentiation. 8 PAX8, p53, WT1, ER and PR were negative, while p16 was positive, in the ovarian tumour described herein. Such a finding is insufficient to constitute evidence of primary OSC; thus, cervical SCC was the primary carcinoma in our case. The probability of metastasis to the ovary from FIGO stage IB-IIIB SCC of the uterine cervix is very low. 1 Haematological metastasis, lymphatic drainage and trans-tubal drainage are possible routes of distant metastasis. 9 The uterine muscle and endometrium were normal but extensive lymphovascular invasion was noted. Thus, haematological metastasis and lymphatic drainage may have been the routes of spread.
It was interesting that the cervical SCC was highly differentiated, while the ovarian and other tumours were poorly differentiated. Eosinophilic cytoplasm forming focal pear-like structures was found locally in the left ovary and was positive for p63, but the other parts of the tumour were negative. This may be the reason for the inter-and intra-tumour heterogeneity. Tumour cells are endowed with different proliferation, metabolic gene expression, motility, and metastatic potential; and have altered morphological and phenotypic profiles. 10 Metastatic squamous cell carcinoma versus primary high grade serous carcinoma of the ovary Based on the clinicopathological and immuno-histochemical data, a diagnosis of ovarian metastasis from cervical carcinoma was confirmed. Management of SCC depends on the histological features and FIGO stage. Most patients can be treated by comprehensive surgery. Adjuvant chemotherapy was subsequently required in this case.
